YAP/TAZ also participates in KRAS oncogene-driven pancreatic ductal carcinoma [28], and KRAS and YAP signaling pathways converge to regulate the epithelia-mesenchymal transition in lung cancer [29]. The gene discussed is KRAS; the disease is pancreatic ductal adenocarcinoma.